|Immunogen||Synthetic peptide analogue of the carboxyl terminal region of C. botulinum Toxin A (Catalog #R01372).|
|Purification||Not Applicable Product is sterile filtered.|
|Target/Specificity||Binds to intact whole C. botulinum Toxin A, amino acids 1280-1292. Has been found to stain Neuro2A cells treated with GTJb ganglioside prior to the addition of C. botulinum Toxin A. Inhibits the entry of C. botulinum Toxin A to Neuro2A cells treated with GTib ganglioside prior to the addition of the toxin. Cross-reactivity:C. botulinum Toxin A (1280-1292) 100%C. botulinum Toxin A 100%C. botulinum Toxin B 0%C. botulinum Toxin C 0%C. botulinum Toxin E 0%C. botulinum Toxin F (1272-1280) 0%|
|Storage||Upon receipt, store at -20°C. Avoid multiple freeze/thaw cycles.1 27 August 2013|
|Precautions||Monoclonal Antibody to Clostridium botulinum Toxin A (a.a. 1280-1292) [B364M] is for research use only and not for use in diagnostic or therapeutic procedures.|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
If you have used an Abgent product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at firstname.lastname@example.org.